N. Ciobanu

820 total citations
24 papers, 672 citations indexed

About

N. Ciobanu is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, N. Ciobanu has authored 24 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 5 papers in Genetics. Recurrent topics in N. Ciobanu's work include Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). N. Ciobanu is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). N. Ciobanu collaborates with scholars based in United States, Moldova and Italy. N. Ciobanu's co-authors include Kim Margolin, David H. Boldt, Geoffrey R. Weiss, Richard I. Fisher, Janice P. Dutcher, Avi B. Markowitz, M Röper, Stephen P. Creekmore, David Parkinson and Karl Welte and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

N. Ciobanu

23 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Ciobanu United States 13 372 285 101 99 98 24 672
Leopold Oehler Austria 13 357 1.0× 173 0.6× 154 1.5× 102 1.0× 192 2.0× 21 762
Monique Stevens Belgium 12 287 0.8× 159 0.6× 119 1.2× 40 0.4× 56 0.6× 15 536
S. Petrasch Germany 17 187 0.5× 194 0.7× 81 0.8× 125 1.3× 37 0.4× 36 642
L J Elwood United States 10 251 0.7× 267 0.9× 183 1.8× 122 1.2× 40 0.4× 12 756
M. Brandely France 14 326 0.9× 262 0.9× 119 1.2× 53 0.5× 164 1.7× 36 760
Cindy Gross United States 8 348 0.9× 175 0.6× 84 0.8× 52 0.5× 105 1.1× 13 694
XX Du United States 11 374 1.0× 297 1.0× 194 1.9× 30 0.3× 262 2.7× 18 790
Mitsuhiro Iwahashi Japan 12 449 1.2× 147 0.5× 153 1.5× 43 0.4× 238 2.4× 18 914
Arthur M. Bobrove United States 9 259 0.7× 133 0.5× 52 0.5× 168 1.7× 47 0.5× 12 626
Charles E. Welander United States 16 117 0.3× 192 0.7× 184 1.8× 70 0.7× 49 0.5× 36 861

Countries citing papers authored by N. Ciobanu

Since Specialization
Citations

This map shows the geographic impact of N. Ciobanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Ciobanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Ciobanu more than expected).

Fields of papers citing papers by N. Ciobanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Ciobanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Ciobanu. The network helps show where N. Ciobanu may publish in the future.

Co-authorship network of co-authors of N. Ciobanu

This figure shows the co-authorship network connecting the top 25 collaborators of N. Ciobanu. A scholar is included among the top collaborators of N. Ciobanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Ciobanu. N. Ciobanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loffredo, Lorenzo, Victoria Ivanov, N. Ciobanu, et al.. (2022). Low-grade endotoxemia and NOX2 in patients with coronary microvascular angina. Kardiologia Polska. 80(9). 911–918. 9 indexed citations
2.
Ciobanu, Cristina, et al.. (2020). Determination of carotenoids in extracts from species of Tagetes and Calendula. SHILAP Revista de lepidopterología. 2 indexed citations
3.
Loffredo, Lorenzo, Victoria Ivanov, N. Ciobanu, et al.. (2020). Is There an Association Between Atherosclerotic Burden, Oxidative Stress, and Gut-Derived Lipopolysaccharides?. Antioxidants and Redox Signaling. 33(11). 761–766. 20 indexed citations
4.
Caraus, Alexandru, et al.. (2020). Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up. European Heart Journal. 41(Supplement_2). 1 indexed citations
5.
6.
Lazarus, Hillard M., et al.. (1994). Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.. PubMed. 14(3). 443–8. 16 indexed citations
7.
Walpole, Euan, Rasim Gucalp, Avi I. Einzig, et al.. (1993). Survival After Phase II Treatment of Advanced Renal Cell Carcinoma with Taxol or High-Dose Interleukin-2. Journal of Immunotherapy. 13(4). 275–281. 20 indexed citations
8.
Crilley, Pamela, Hillard Lazarus, David Topolsky, et al.. (1993). Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies.. PubMed. 20(4 Suppl 4). 50–4; quiz 55. 14 indexed citations
9.
Ciobanu, N., et al.. (1992). Experience with autologous bone marrow harvesting and transfusion of marrow‐derived red cells. Transfusion. 32(3). 231–234. 1 indexed citations
10.
Lazarus, Hillard M., N. Ciobanu, Richard J. Creger, et al.. (1992). High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.. Journal of Clinical Oncology. 10(11). 1682–1689. 67 indexed citations
11.
Marcus, Stuart L., JP Dutcher, Elisabeth Paietta, et al.. (1991). Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cells. American Journal of Clinical Nutrition. 54(6). 1292S–1297S. 25 indexed citations
12.
Margolin, Kim, Frederick R. Aronson, Mario Sznol, et al.. (1991). Phase II Trial of High-Dose Interleukin-2 and Lymphokine-Activated Killer Cells in Hodgkin??s Disease and Non-Hodgkin??s Lymphom. Journal of Immunotherapy. 10(3). 214–220. 21 indexed citations
13.
Bar, M H, Mario Sznol, Michael B. Atkins, et al.. (1990). Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells.. Journal of Clinical Oncology. 8(7). 1138–1147. 66 indexed citations
14.
Gaynor, Ellen R., M H Bar, David H. Boldt, et al.. (1989). Phase i study of high dose continuous infusion interleukin 2 and autologous lymphokine activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma. 30. 239. 1 indexed citations
15.
Dutcher, Janice P., Stephen P. Creekmore, Geoffrey R. Weiss, et al.. (1989). A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.. Journal of Clinical Oncology. 7(4). 477–485. 180 indexed citations
16.
Ciobanu, N., et al.. (1987). Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma.. PubMed. 71(12). 1324–5. 4 indexed citations
17.
Wiernik, Peter H., et al.. (1987). Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy. Journal of Cancer Research and Clinical Oncology. 113(5). 495–497. 2 indexed citations
18.
Welte, Karl, N. Ciobanu, Charlotte Cunningham‐Rundles, et al.. (1984). Interleukin-2 correction of defectivein vitro T-cell mitogenesis in patients with common varied immunodeficiency. Journal of Clinical Immunology. 4(4). 295–303. 77 indexed citations
19.
Welte, Karl, Salvatore Venuta, N. Ciobanu, et al.. (1983). Human Interleukin 2: Physiology, Biochemistry, and Pathophysiology in Lymphoblastic Leukemias and Immunodeficiency Syndromes. Hämatologie und Bluttransfusion. 28. 369–379. 10 indexed citations
20.
Flomenberg, Neal, Karl Welte, R Mertelsmann, et al.. (1983). Immunologic effects of interleukin 2 in primary immunodeficiency diseases. The Journal of Immunology. 131(5). 2609–2609. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leopold Oehler Breakdown of academic impact, for papers by Monique Stevens Breakdown of academic impact, for papers by S. Petrasch Breakdown of academic impact, for papers by L J Elwood Breakdown of academic impact, for papers by M. Brandely Breakdown of academic impact, for papers by Cindy Gross Breakdown of academic impact, for papers by XX Du Breakdown of academic impact, for papers by Mitsuhiro Iwahashi Breakdown of academic impact, for papers by Arthur M. Bobrove Breakdown of academic impact, for papers by Charles E. Welander
Rankless by CCL
2026